Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04778761 · ClinicalTrials.gov registry record · NA

ACP Video Intervention for Patients With Life-Limiting Illness

A NA study of Health Care Utilization and End Stage Disease, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT04778761: Recruiting NA study of Health Care Utilization and End Stage Disease, sponsored by Massachusetts General Hospital.

NCT04778761 is a NA study of Health Care Utilization and End Stage Disease that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 500 participants, below the 901-participant average among 25 other Health Care Utilization trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04778761, a NA study of Health Care Utilization and End Stage Disease, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.

Primary Outcome

Compare the use of hospice (yes vs. no) between the study groups

Interventions

  • BEHAVIORAL Home ACP Video

Study Locations (1)

New Jersey

  • Clover Health - Jersey City

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-04-01
Est. Completion 2027-12-01
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT04778761 shows while recruiting

NCT04778761 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 901-participant average among 25 other Health Care Utilization trials with a reported enrollment target (45% lower).

The record links to 2 conditions, with Health Care Utilization appearing as the primary indexed condition, and to 1 intervention - of which Home ACP Video is the first listed.

NCT04778761 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT04778761 about?

NCT04778761 is a clinical study titled "ACP Video Intervention for Patients With Life-Limiting Illness". The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.

What is the current status of trial NCT04778761?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2021-04-01. Estimated completion is 2027-12-01.

What conditions does trial NCT04778761 study?

This clinical trial studies the following conditions: Health Care Utilization, End Stage Disease.

What interventions are being tested in trial NCT04778761?

The interventions under investigation include: Home ACP Video (BEHAVIORAL).

Who is sponsoring clinical trial NCT04778761?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04778761 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Care Utilization

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04778761's enrollment target sits among peer trials

500 10th of 25 higher than 16 of 25 other Health Care Utilization trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Health Care Utilization trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04778761, the US trial registry maintained by the National Library of Medicine. NCT04778761 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.